Grupo Procrearte

What Grupo Procrearte does

Grupo Procrearte (legal entity: PROCREARTE S.A.) is a Buenos Aires-headquartered reproductive medicine network founded in 1999 that operates the largest such network in Latin America, with eight clinical sites across Argentina (Buenos Aires, La Plata, Pilar, Rafaela, Resistencia, Trenque Lauquen, Santa Fe) and a presence in Uruguay, staffed by more than 100 specialized professionals. The company delivers a full-stack reproductive medicine service: low- and high-complexity assisted reproduction (intrauterine insemination, IVF, ICSI), Argentina's largest ovodonación (egg donation) program, the country's first dedicated egg bank (Maternity Bank), fertility preservation for medical and social indications, surrogacy, ROPA method for female couples, HIV serodiscordant sperm services, and a comprehensive molecular genetics division spanning carrier screening, PGT-A/SR/M, NIPT, neonatal screening, and pregnancy-loss studies. Adjacent offerings include nutritional counseling with nutrigenetic testing (Procrearte Bienestar), emotional coaching (Bio Fertility Coach), and a formal technology and AI/genetics innovation unit (Procreartech).

The company generates revenue primarily through fee-for-service clinical treatments paid either out-of-pocket (quotes issued via [email protected]) or via coverage from more than 20 prepagas and obras sociales (notably OSDE, Swiss Medical, Medifé, Omint), with recurring annual cryopreservation maintenance fees creating a subscription-style tail. Distribution runs through direct patient consultations scheduled online or via WhatsApp, plus a referral channel via in-network physicians and insurance partners; an academic affiliation with the UBA Faculty of Medicine (since 2010) and a 24-month SAMER-certified fellowship pipeline add credentialing and talent-formation functions. The company operates as a private founder/institutionally-managed corporation with no disclosed external investors, parent company, or funding rounds.

Name

Grupo Procrearte

Legal name

PROCREARTE S.A.

Website

https://procrearte.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Grupo Procrearte is the largest reproductive medicine network in Latin America, operating eight clinics across Argentina and Uruguay that deliver IVF/ICSI, egg donation, fertility preservation, preimplantation genetic testing, and adjacent wellness services to insured and private-pay patients.

Ownership category

akta.pro rank

Product category

Reproductive medicine and fertility services

NAICS

Family Planning Centers (621410)

akta.pro primary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

akta.pro secondary industries

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF)

Keywords

• Assisted reproductive technology
• In vitro fertilization services
• Preimplantation genetic testing
• Egg donation programs
• Fertility preservation services

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Fertility Treatment Services: Revenue generated from providing assisted reproduction treatments including intrauterine insemination, IVF/ICSI, egg donation, egg vitrification/preservation, ROPA method, surrogacy, sperm donation, and added practices. Treatments are offered both to patients with insurance coverage (prepagas and obras sociales) and private pay patients.
2. Medical Consultations and Appointments: Revenue from medical consultation appointments across various specialties including fertility, gynecology, andrology, genetics, and ultrasound. Administrative coverage counseling also provided.
3. Genetic Testing Services: Revenue from genetic testing services including Carrier Screening, PGT-A, PGT-SR, PGT-M, fetal DNA testing, endometrial receptivity testing, and neonatal genetic testing. Results typically delivered within 7-30 days depending on test type.
4. Nutritional and Wellness Services: Revenue from fertility-focused nutritional counseling and nutrigenetic testing services aimed at improving reproductive health outcomes.
5. Annual Maintenance Fees: Annual fees for maintaining cryopreserved biological material (embryos, oocytes, sperm). Contact via [email protected].
6. Bio Fertility Coaching Services: Emotional support and coaching services for fertility patients, provided by specialized coaches like Lic. Mariel Chiera, available via virtual consultations.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Grupo Procrearte is a reproductive medicine and molecular genetics provider that delivers assisted reproduction treatments (IUI, IVF/ICSI, egg donation, ROPA method, surrogacy, fertility preservation, sperm donation, and HIV serodiscordant sperm selection) along with advanced genetic testing (PGT-A/SR/M, carrier screening, NIPT, endometrial receptivity, neonatal screening, pregnancy-loss studies). It operates the largest reproductive medicine network in Latin America with 100+ professionals across multiple Argentine provinces and Uruguay, complemented by nutritional wellness counseling, Bio Fertility Coach emotional support, and a Procreartech AI/genetics innovation unit.

Product overview

Grupo Procrearte operates as a comprehensive reproductive medicine network, the largest in Latin America, offering a unified platform of clinical, laboratory, and wellness services. The core offering spans assisted reproduction treatments (IUI, IVF/ICSI, egg donation, ROPA method, surrogacy, fertility preservation, HIV sperm selection, and semen donation), augmented by a robust genetic and molecular medicine division (carrier screening, preimplantation testing PGT-A/SR/M, fetal DNA testing, neonatal screening, and pregnancy loss studies). Adjacent services include nutritional counseling (Nutrición Fértil, nutrigenetic testing), emotional coaching (Bio Fertility Coach), and a technology innovation unit (Procreartech). The product portfolio functions as an integrated care ecosystem where patients progress from diagnosis through treatment and follow-up, with genetic testing and wellness services designed to support and optimize clinical outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Maternity Bank: First and only egg bank in Argentina offering comprehensive maternity preservation services.
• Procreartech
• Bio Fertility Coach
• Procrearte Bienestar

Products and services

• Programa de Ovodonación (Egg Donation Program) Argentina's largest egg donation program, intended for couples who require donor oocytes to achieve pregnancy; involves donor selection on physical similarity, cycle synchronization, IVF, embryo culture, Day 5 (blastocyst) embryo transfer and cryopreservation of surplus embryos.
• Maternity Bank Egg Vitrification and Storage First and only egg bank in Argentina offering integral maternity-preservation services, including oocyte vitrification at -196 degrees Celsius and storage for women who wish to preserve fertility for medical (e.g., oncological) or social reasons.
• Inseminación Intrauterina (IUI) Intrauterine insemination, the simplest assisted reproduction technique, depositing partner or donor sperm into the uterus at ovulation for couples with mild infertility, single women, or female couples.
• Fertilización In Vitro (IVF/ICSI) High-complexity assisted reproduction procedures: conventional IVF placing 100–200 thousand sperm per oocyte, and ICSI injecting a single sperm directly into each oocyte cytoplasm, for severe male factor, tubal factor, or failed IUI cases.
• Método ROPA (Shared Motherhood IVF) Technique enabling two women in a couple to share the IVF process actively, with one woman providing the oocyte (genetic mother) and the other carrying the pregnancy (biological mother).
• Gestación Subrogada (Surrogacy) Surrogacy arrangements for individuals or couples who cannot carry a pregnancy due to absence or condition of the uterus or medical contraindications to pregnancy.
• Preservación de Fertilidad (Fertility Preservation) Fertility preservation services for medical indications (e.g., before chemotherapy or autoimmune treatment) and social indications (planned delay of motherhood), covering oocyte and sperm cryopreservation.
• Reproducción para Parejas Serodiscordantes (HIV) Sperm selection and study service for HIV-positive men, enabling safe reproduction through IUI or IVF by removing and testing sperm to prevent viral transmission.
• Donación de Semen Donor semen services for couples without viable sperm, single women, or female couples requiring donor samples for IUI or IVF.
• Genética y Medicina Molecular (Preconception, Prenatal and Postnatal Genetic Testing) Comprehensive genetic testing services spanning preconception carrier screening, preimplantation genetic testing (PGT-A, PGT-SR, PGT-M), fetal DNA in maternal blood (NIPT), neonatal screening, and pregnancy-loss analysis, for couples and patients seeking genetic risk assessment before, during, or after pregnancy.
• PGT-A (Preimplantation Genetic Testing for Aneuploidies) Preimplantation genetic test for aneuploidies that uses NGS to evaluate gains or losses of any chromosome in embryos, intended to increase pregnancy rates per transfer from 30–40% to 60–70% and reduce miscarriage risk.
• PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) Preimplantation genetic test using NGS for couples with balanced chromosomal translocations, intended to reduce risk of transferring a chromosomally unbalanced embryo.
• PGT-M (Preimplantation Genetic Testing for Monogenic Diseases) Preimplantation genetic test evaluating specific genes altered in one or both partners across more than 7,000 known disease-associated genes, applicable to couples carrying single-gene disorders and intended to reduce the probability of having an affected child by more than 95%.
• ADN Fetal en Sangre Materna (NIPT) Non-invasive prenatal testing (NIPT) analyzing fetal DNA in maternal blood from week 10 of gestation, available in Standard, Plus and Advanced panels covering chromosomal and microdeletion anomalies, with detection rates above 99% for trisomies 21, 18 and 13.
• Test Genético Neonatal Neonatal genetic test using a buccal swab to evaluate more than 300 serious childhood-onset diseases, with results returned in approximately 30 days.
• Estudio de Pérdida de Embarazo Genetic analysis service for couples experiencing pregnancy loss, identifying chromosomal causes (which account for approximately 70% of miscarriages) and providing family genetic counseling.
• Carrier Screening (Estudio de Portadores) Preconception genetic carrier screening analyzing at least 300 genes associated with recessive monogenic diseases using NGS, intended to identify couples at risk of having affected offspring before pregnancy.
• Nutrición Fértil (Fertility Nutrition Counseling) Fertility-focused nutritional counseling service intended to improve reproductive health outcomes, including nutrigenetic testing to personalize dietary recommendations.
• Test de Nutrigenética DNA-based nutrigenetic test providing information on metabolism, oxidative stress, autoimmune and metabolic disease risk, and physical condition to personalize nutrition and lifestyle recommendations for patients undergoing fertility treatment.
• Bio Fertility Coach Emotional support and professional coaching service for patients undergoing fertility treatment, providing personalized guidance, anxiety management tools, and emotional-wellness support throughout the reproductive journey, available via virtual consultations.

Quantifiable outcome

• PGT-A increases pregnancy rate per transfer from 30-40% to 60-70%
• +6 more outcomes

Named customers20 records

Segments11 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature13 records

Partnerships

Five partnerships are on record, tiered core.

• Universidad de Buenos Aires (UBA) - Faculty of MedicinecoreStrategic or Co-development Partner · 28 June 2010Procrearte was accredited as an Affiliated Institution to the Faculty of Medicine of the University of Buenos Aires on June 28, 2010 by resolution No. 1015. This status is granted to healthcare institutions and/or basic or applied research institutes that develop postgraduate activities and meet the academic, scientific, teaching, research, and ethical standards required by the university.
• Sociedad Argentina de Medicina Reproductiva (SAMER)coreStrategic or Co-development PartnerFellowship program in reproductive medicine (24 months, 2026-2028) jointly certified by Procrearte and SAMER. Fellows must complete SAMER's Superior Course if not already done.
• Maternity BankcoreTechnology or IntegrationFirst and only egg bank in Argentina for maternity preservation, offering integral egg preservation services. Operated as part of Procrearte's comprehensive fertility preservation offerings.
• OSDEcoreChannel Partner/ Reseller/ DistributorMajor health insurance provider with special authorization processing directly managed by Procrearte. Patients with OSDE coverage have authorizations processed through Procrearte's authorization department.
• Prepagas and Obras Sociales NetworkcoreChannel Partner/ Reseller/ DistributorCoverage agreements with over 20 health insurers including Medicus, Medifé, Medifé Interior, Omint, OSDOP, OSMATA, OSPOCE, OSSEG, OSUTHGRA, Swiss Medical, TV Salud, William Hope, C. Médico Pueyrredon, Futbolistas Agremiados, Luis Pasteur, Sempre, Serv. Penitenciario, SIMEPA, Poder Judicial.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Others

• Vitrolife: Global supplier of IVF media, disposables and genetic testing services (incl. PGT). Adjacent supplier enabling the same IVF and PGT workflow that Procrearte delivers; relevant ecosystem comparable rather than direct competitor.

Direct peers

• Centro de Estudios en Ginecología y Reproducción (CEGyR): Buenos Aires-based reproductive medicine center offering IVF, ICSI, egg/sperm donation, fertility preservation and genetic testing. Direct Argentine peer with overlapping clinical service mix and patient segments.
• Fecunditas: Argentine fertility center (Instituto Médico Integral de Fertilidad) offering IVF, ICSI and andrology services. Direct peer; Procrearte's Dr. Carlos Carrere and Dr. Juan Carlos Mannara previously served at Fecunditas.
• Halitus Instituto Médico: Long-standing Argentine reproductive medicine clinic in Buenos Aires offering IVF, ICSI, egg donation and andrology. Direct domestic competitor; multiple Procrearte directors (e.g., Dra. Liliana Blanco) previously led or worked at Halitus.

Broad incumbents

• Inception Fertility: US-based fertility services platform operating multiple clinic brands (e.g., Shady Grove Fertility). Comparable in offering IVF, PGT and fertility preservation at scale; broad incumbent reference for Procrearte's network model.
• IVI / IVI-RMA Global: World's largest fertility treatment network (formerly IVI in Spain, now IVI-RMA following KKR-backed merger with RMA US). Competes with Procrearte's full IVF/PGT stack and represents the dominant global incumbent in reproductive medicine.
• CCRM Fertility: US fertility clinic network known for clinical research and high-complexity IVF/PGT. Comparable in advanced reproductive technology offering and multi-site operating model; an established global benchmark.

Regional players

• Virtus Health: Australia-headquartered fertility clinic network (IVFAustralia, TasIVF, The Fertility Centre). Comparable multi-site IVF platform operating in a different geography; useful comp for clinic-level economics.
• Genea Biomedx / Genea Fertility: Australian fertility clinic network with proprietary embryology and lab technology (Genea Biomedx). Comparable in integrated clinical-and-tech approach; regional player with similar verticalized model in a different geography.

Emerging players

• New Hope Fertility Center: US fertility clinic known for natural/mild-stimulation IVF protocols and strong digital patient experience. Comparable clinical offering; emerging positioning in differentiated protocols and patient engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/procrearte
• Facebookfacebook.com/procrearte
• LinkedInlinkedin.com/company/grupo-procrearte

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Procrearte